Effects of sitagliptin addition versus sulfonylurea intensification on beta cell function in patients with type 2 diabetes inadequately controlled on sulfonylurea: a randomized, multicenter, open-label trial.
Phase of Trial: Phase IV
Latest Information Update: 01 Dec 2015
At a glance
- Drugs Sitagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 Oct 2012 Last checked against University Hospital Medical Information Network - Japan record.
- 19 Feb 2011 New trial record